J 2017

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

SMID, D.E., F.M.E. FRANSSEN, M. GONIK, M. MIRAVITLLES, C. CASANOVA et. al.

Basic information

Original name

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

Authors

SMID, D.E. (528 Netherlands), F.M.E. FRANSSEN (528 Netherlands), M. GONIK (276 Germany), M. MIRAVITLLES (724 Spain), C. CASANOVA (724 Spain), B.G. COSIO (724 Spain), P. de LUCAS-RAMOS (724 Spain), J.M. MARIN (724 Spain), C. MARTINEZ (724 Spain), I. MIR (724 Spain), J.B. SORIANO (724 Spain), J.P. de TORRES (724 Spain), A. AGUSTI (724 Spain), N.B. ATALAY (792 Turkey), J. BILLINGTON (826 United Kingdom of Great Britain and Northern Ireland), A.K. BOUTOU (300 Greece), S. BRIGHENTI-ZOGG (756 Switzerland), E. CHAPLIN (826 United Kingdom of Great Britain and Northern Ireland), S. COSTER (826 United Kingdom of Great Britain and Northern Ireland), J.W. DODD (826 United Kingdom of Great Britain and Northern Ireland), S. DURR (756 Switzerland), A. FERNANDEZ-VILLAR (724 Spain), M.T.J. GROENEN (528 Netherlands), M. GUIMARAES (620 Portugal), Karel HEJDUK (203 Czech Republic, guarantor, belonging to the institution), V. HIGGINS (826 United Kingdom of Great Britain and Northern Ireland), N.S. HOPKINSON (826 United Kingdom of Great Britain and Northern Ireland), N. HORITA (392 Japan), S. HOUBEN-WILKE (528 Netherlands), D.J.A. JANSSEN (528 Netherlands), M. JEHN (276 Germany), R. JOERRES (276 Germany), A. KARCH (276 Germany), J.L. KELLY (826 United Kingdom of Great Britain and Northern Ireland), Y.I. KIM (410 Republic of Korea), H. KIMURA (392 Japan), V. KOBLIZEK (203 Czech Republic), J.H. KOCKS (528 Netherlands), S.S.C. KON (826 United Kingdom of Great Britain and Northern Ireland), N. KWON (826 United Kingdom of Great Britain and Northern Ireland), I. LADEIRA (620 Portugal), S.D. LEE (410 Republic of Korea), J.D. LEUPPI (756 Switzerland), N. LOCANTORE (840 United States of America), J.L. LOPEZ-CAMPOS (724 Spain), W.D.C. MAN (826 United Kingdom of Great Britain and Northern Ireland), L. MARICIC (191 Croatia), L. MENDOZA (152 Chile), D. MIEDINGER (756 Switzerland), F. MIHALTAN (642 Romania), S. MINAMI (392 Japan), T. van der MOLEN (528 Netherlands), T.J. MURRELLS (826 United Kingdom of Great Britain and Northern Ireland), N. NAKKEN (528 Netherlands), Y. NISHIJIMA (392 Japan), I.J. NORMAN (826 United Kingdom of Great Britain and Northern Ireland), B. NOVOTNA (203 Czech Republic), D.E. O DONNELL (124 Canada), Y. OGATA (392 Japan), E.D. PEREIRA (76 Brazil), J. PIERCY (826 United Kingdom of Great Britain and Northern Ireland), D. PRICE (826 United Kingdom of Great Britain and Northern Ireland), C. POTHIRAT (764 Thailand), N. RAGHAVAN (124 Canada), T. RINGBAEK (208 Denmark), D. SAJKOV (36 Australia), N. SIGARI (368 Iraq), S. SINGH (826 United Kingdom of Great Britain and Northern Ireland), M. SMALL (826 United Kingdom of Great Britain and Northern Ireland), G.F. DA SILVA (76 Brazil), R.J. TANNER (826 United Kingdom of Great Britain and Northern Ireland), I.G. TSILIGIANNI (528 Netherlands), B. TULEK (300 Greece), N. TZANAKIS (528 Netherlands), L.E.G.W. VANFLETEREN (528 Netherlands), H. WATZ (528 Netherlands), K.A. WEBB (124 Canada), E.F.M. WOUTERS (528 Netherlands), G.G. XIE (156 China), M. YOSHIKAWA (392 Japan) and M.A. SPRUIT (528 Netherlands)

Edition

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, NEW YORK, ELSEVIER SCIENCE INC, 2017, 1525-8610

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30227 Geriatrics and gerontology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 5.325

RIV identification code

RIV/00216224:14110/17:00099170

Organization unit

Faculty of Medicine

UT WoS

000416478400025

Keywords in English

COPD; GOLD; health status; clinical significance

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 13:14, Soňa Böhmová

Abstract

V originále

Background: Patients with chronic obstructive pulmonary disease (COPD) can be classified into groups A/C or B/D based on symptom intensity. Different threshold values for symptom questionnaires can result in misclassification and, in turn, different treatment recommendations. The primary aim was to find the best fitting cut-points for Global initiative for chronic Obstructive Lung Disease (GOLD) symptom measures, with an modified Medical Research Council dyspnea grade of 2 or higher as point of reference. Methods: After a computerized search, data from 41 cohorts and whose authors agreed to provide data were pooled. COPD studies were eligible for analyses if they included, at least age, sex, post-bronchodilator spirometry, modified Medical Research Council, and COPD Assessment Test (CAT) total scores. Main outcomes: Receiver operating characteristic curves and the Youden index were used to determine the best calibration threshold for CAT, COPD Clinical Questionnaire, and St. Georges Respiratory Questionnaire total scores. Following, GOLD A/B/C/D frequencies were calculated based on current cut-points and the newly derived cut-points. Findings: A total of 18,577 patients with COPD [72.0% male; mean age: 66.3 years (standard deviation 9.6)] were analyzed. Most patients had a moderate or severe degree of airflow limitation (GOLD spirometric grade 1, 10.9%; grade 2, 46.6%; grade 3, 32.4%; and grade 4, 10.3%). The best calibration threshold for CAT total score was 18 points, for COPD Clinical Questionnaire total score 1.9 points, and for St. Georges Respiratory Questionnaire total score 46.0 points. Conclusions: The application of these new cut-points would reclassify about one-third of the patients with COPD and, thus, would impact on individual disease management. Further validation in prospective studies of these new values are needed. (C) 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.